What this is
- This umbrella review synthesizes findings from 72 meta-analyses on the prevalence of mental health issues among healthcare professionals (HCPs) during the COVID-19 pandemic.
- It focuses on , , , and , providing a quantitative summary of their prevalence.
- The review aims to inform policy decisions and interventions to support HCPs' mental health during crises.
Essence
- Healthcare professionals experienced high rates of mental health issues during the COVID-19 pandemic, with at 37%, at 31.8%, at 29.4%, and at 36.9%. These findings underscore the urgent need for targeted mental health interventions.
Key takeaways
- prevalence among healthcare professionals was 37%, indicating a significant mental health burden. This high rate reflects the challenges faced during the pandemic, including increased responsibilities and emotional strain.
- affected 31.8% of HCPs, with higher rates observed among nurses compared to physicians. This disparity suggests that nurses may face greater psychological due to their closer contact with patients.
- was reported in 36.9% of HCPs, highlighting the impact of the pandemic on sleep quality. Addressing sleep issues is crucial for improving overall mental health and well-being among healthcare workers.
Caveats
- Selection bias may exist as non-English meta-analyses were excluded, potentially limiting the generalizability of findings. Additionally, overlapping studies in different meta-analyses could affect prevalence estimates.
- Variations in methodologies across primary studies may influence the accuracy of prevalence estimates for , , , and . Future research should standardize assessment tools to improve comparability.
Definitions
- Stress: The degree to which individuals perceive situations in their lives as stressful.
- Anxiety: A state of excessive fear that manifests as behavioral disturbances.
- Depression: A set of symptoms including depressed mood, loss of pleasure, and fatigue lasting at least two weeks.
- Sleep disturbance: A range of sleep-related problems, including poor-quality sleep and disruptions in the sleep-wake cycle.
AI simplified
1. Introduction
In December 2019, the coronavirus disease 2019 (COVID-19) pandemic emerged in Wuhan, China. The disease quickly spread worldwide, and the WHO declared a global health emergency in March 2020 [1]. Due to the COVID-19 pandemic, many countries implemented various measures to prevent the spread of the disease. These included implementing a partial or complete lockdown and social distancing strategies of varying intensity. The measures taken by these countries also affected the livelihood of individuals, an occurrence which might directly or indirectly also increase psychological morbidities. Undoubtedly, pandemics have a long history of impacting physical and mental health for different population groups, and HCPs are typically the most affected group in terms of bearing the burden of these illnesses [2]. In addition, several researchers have shown that work-related psychological disorders, including stress, anxiety, depression, and burnout, had already negatively affected the healthcare system before the COVID-19 pandemic, leading to low-quality care and high malpractice litigation [3β5].
As a result of the pandemic, HCPs experienced various changes in their personal and professional lives. For some, these included being given more responsibility, having to re-learn how to effectively control the infection, and dealing with the emotional impact of caring for infected and dying COVID-19 patients [6]. The alteration in their work environment, as well as the likelihood that they might acquire the infection themselves, can also affect their personal mental health. It is almost inevitable that the experiences of HCPs went through during the pandemic put them at heightened risk of stress, anxiety, depression, and sleep disturbance [7,8]. It is important to understand the effects of the pandemic on the mental health and well-being of HCPs in order to help plan strategies to prevent these individuals from experiencing detrimental effects, and to ensure that they can continue to deliver healthcare services.
During previous viral outbreaks including the Severe Acute Respiratory Syndrome (SARS) and the Middle East Respiratory Syndrome (MERS) epidemics, HCPs were placed under extraordinary amounts of pressure [9,10]. Indeed, evidence suggested that HCPs suffered from high levels of stress, anxiety, depression and sleep disturbance during these outbreaks [11,12]. A high prevalence of mental health problems can adversely impact the quality of life of HCPs, increase disability, turnover, absenteeism, and errors, and can deleteriously affect patient outcomes which may lead to low patient satisfaction [13]. Further, it might increase suicidal ideation or self-harming among HCPs [14].
In the present review, four phenomena were addressed. Sleep disturbance refers to a range of sleep-related problems, including disruptions in the bodyβs natural sleep-wake cycle, insufficient or poor-quality sleep, and sleep disorders [15]. The anxiety symptoms were defined as a state of excessive fear that translates to behavioural disturbances [16]. Major depressive disorder is a set of symptoms that includes depressed mood, loss of pleasure or interest, fatigue, changes in sleep and activity levels, and other symptoms, with a minimum duration of two weeks and at least five or more symptoms present according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [16]. Cohen et al., [17] define stress as βthe degree to which individuals appraise situations in their lives as stressfulβ. In this umbrella review, stress, anxiety, depression, and sleep disturbance symptoms were defined based on the validated scales/questionnaires that assess each phenomenon in the original studies.
Several primary studies and, subsequently, systematic reviews and meta-analyses have been carried out to identify the prevalence of mental health problems among HCPs during the COVID-19 pandemic. Additionally, three umbrella reviews of meta-analyses [18β20] have been published previously, but the number of meta-analyses included in both cases did not exceed twenty. Since their publication, further meta-analyses have estimated the prevalence of stress, anxiety, depression, and sleep disturbance during the COVID-19 pandemic. The advantages of umbrella reviews include their ability to provide a comprehensive analysis of the literature, in this case about the prevalence of various mental disorders in HCPs during the COVID-19 pandemic. In addition, the results can then be used to make policy-level decisions to improve the quality of clinical care in terms of making clinical risk predictions and can inform future research priorities. Therefore, the aim of this umbrella review is to quantify meta-analytic findings aimed at estimating the prevalence symptoms of stress, anxiety, depression, and sleep disturbance among HCPs during the COVID-19 pandemic.
2. Methods
The umbrella review and meta-analysis were carried out according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines [21]. The review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) database and can be accessed online (CRD42022364721).
2.1 Search strategy
A systematic search was conducted to identify relevant meta-analyses in various electronic databases published between 1st January 2020 and 15th January 2024. The databases searched were PubMed, CINAHL, MEDLINE, EMBASE, PsycINFO, and Google Scholar. The search terms strategy used Medical Subject Headings (MeSH) and free text words with Boolean operators and truncations (AND/OR/NOT). The key search terms included (MH "Coronavirus Infections+") OR "COVID-19β OR "COVIDβ OR "coronavir* OR "Coronavirus" OR "SARS-COV2" AND "Health care provider" OR "health care professional" OR "healthcare provider*" OR (MH "Nurses+") OR (MH "Medical Staff") OR (MH "Physician") OR (MH "Medical Doctor") OR (MH "Staff Nurses") OR "nursing staff" OR "health personnel or health professional or nurse" OR "health personnel or health professional or nurse" AND "Stress" OR "post-traumatic stress disorder" OR "panic disorder" OR "obsessive compulsive disorder OR "anxi*" OR (MH "Anxiety Disorders+") OR (MH "Anxiety+") OR (MH "Depression+") OR "depress*" OR (MH "Affective Symptoms+") OR (MH "Affective Disorders+") OR (MH "Bipolar Disorder+") OR "affective" OR "mood" OR "mental" OR (MH "Mental Disorders+") OR (MH "Mental OR "psycho*" OR (MH "Insomnia+") OR (MH "Circadian Rhythm+") OR (MH "Sleep Disorders+") OR (MH "Insomnia+") OR (MH "Sleep+") AND "Systematic Review" OR "Meta-Analysis" OR "Meta-Analytic". Additionally, the reference lists were searched to find any other studies.
2.2 Study selection
Two reviewers (A.M.; A.A.) independently extracted the data from the search, scrutinizing all titles and abstracts for eligibility against the inclusion and exclusion criteria. A third reviewer (G.D.) was available to resolve any disagreements through discussion. Systematic reviews incorporating meta-analyses were included according to the following criteria. The studies: (1) examined the prevalence of stress or anxiety or depression or sleep disturbance symptoms; (2) presented results for HCPs as a group or separately (e.g., nurses or physicians only); further, studies involving non-HCPs must have presented results for HCPs separately and not pooled with non-HCPs.; (3) were conducted during the COVID-19 pandemic; (4) were published in English; (5) involved a systematic review with meta-analysis. Studies were excluded if (1) these consisted of a systematic review without meta-analysis; (2) consisted of a literature review or a narrative review (3) the participants were general population or non-HCPs.
2.3 Quality assessment
The methodological quality assessment of each meta-analysis was blindly rated by two reviewers using the Assessment of Multiple Systematic Reviews (AMSTAR-2) tool [22]. This scale consists of 16 items that evaluate the risk of bias of a systematic review. Items 1, 3, 5, 6, 10, 13, 14, and 16 are evaluated with either a "Yes" or "No" response. Items 2, 4, 7, 8, and 9 are evaluated with "Yes," "Partial Yes," or "No" responses. Items 11, 12, and 15 are evaluated with "Yes," "No," or "No meta-analysis conducted" responses. The overall rating can be rated as "High," "Moderate," "Low," or "Critically low."
2.4 Credibility of evidence
The credibility of the evidence of each association provided was evaluated by the Fusar-Poli and Radua [23] classification criteria. The level of evidence as convincing (class I) when specific criteria were met, including more than 1000 cases, p<10β6, I2 higher than 50%, 95% prediction intervals excluding the null, no small-study effects, and no publication bias. If the number of cases exceeded 1000, p<10β6, the largest study showed a statistically significant effect, but not all class I criteria were satisfied; the evidence level was considered highly suggestive (class II). When there were over 1000 cases, p<10β3, but no other class I or II criteria were met, the evidence level was termed suggestive (class III). If no class I-III criteria were met, the evidence level was classified as weak (class IV). The fourth level, termed weak evidence (class IV), included associations with a p β€0.05, but these associations did not meet the criteria for class I, class II, or class III. The fifth level, denoted as non-significant (NS), comprised associations with a pΛ0.05.
2.5 Data analyses
There are two methods exist for deriving effect size estimates from existing meta-analyses. The first approach involves conducting a meta-analysis on the effect size estimates taken from individual studies included in multiple prior meta-analyses [24]. However, this method demands significant time and resources. Furthermore, it contradicts the primary purpose of an umbrella review because it requires return to the original studies.
The second approach employs a statistical technique to efficiently summarize data from previous meta-analyses without the need to go back to the individual studies. This method relies solely on the summary effect sizes and their associated variances provided in the original meta-analyses [25]. It calculates an overall effect size for the combined meta-analyses by computing a weighted average of the summary effect sizes, with the weights determined by the inverse of the variances [26]. This approach is similar to the methods used in meta-analyses of primary studies. Although the second approach (combining summary effect sizes) may not achieve the same level of precision as the first method (combining all individual studies), empirical tests have confirmed its ability to generate a statistically valid estimate for the overall effect size [27,28]. In this umbrella review, we employed the second approach, which entailed the utilization of aggregate data derived from the meta-analyses.
The analyses were conducted using R software, version 4.3.1 (R Foundation for Statistical Computing), with packages used βmetaβ [29], βmetaforeβ [30] and βmetaumbrellaβ[31]. Pooled estimates prevalence with 95% Confidence Intervals (CIs) was conducted using random effect models, and the results were reported on a forest plot. In addition, the I-squared (I2) test was used to assess the statistical heterogeneity of the included meta-analyses. A value of I2 < 25% was considered low, 25β50% moderate, and Λ 50% high [32]. Subgroup analyses were performed when there were at least four meta-analyses per subgroup.
Publication bias was assessed using Eggerβs test with a p < 0.10 indicates a statistically significant small-study effect [33]. Statistical significance was set at p<0.05. If publication bias was identified, trim and fill methods were used to adjust the publication bias [34]. A sensitivity analysis was conducted in which individual meta-analyses were systematically removed one at a time to assess how they affected the overall combined prevalence of the remaining meta-analyses [35], with the aim of clarifying the stability and reliability of the finding [36].
3. Result
A total of 1,987 papers were identified through the database search. Out of these, 1,843 were excluded at the abstract and title screening stage for the following reasons: 786 were duplicates, 443 did not include a meta-analysis, 392 lacked information about prevalence, 139 lacked information about HCP status, and 83 were not conducted during the period of the COVID-19 pandemic. A further 72 papers were excluded during the full text review process. As a result, 72 meta-analyses were eligible for umbrella review (Fig 1).
PRISMA diagram.
3.1 General characteristics of the studies included
The included 72 meta-analyses [37β108]. Fifty-four of the meta-analyses dealt with HCPs in general, whereas two meta-analyses reported the situation only with regard to physicians or nurses [44,59], three meta-analyses dealt with nurses [49,79,91], and one dealt with physicians [88], while 17 meta-analyses included a mixed population (General and HCPs),(Only data specifically related to healthcare professionals were included in the umbrella review analysis). The most commonly used statistical software was STATA (n = 32), R (n = 17) and comprehensive meta-analysis (n = 11). Twenty-four meta-analyses used the NewcastleβOttawa scale to assess the quality of the studies. Forty-six meta-analyses included mixed studies from different countries, twenty-five meta-analyses were conducted in specifical geographical areas: 10 for China, five for India, four for Asia two for Bangladesh and Ethiopia and one for each of the following: Egypt, South Asia, and Vietnam. The detailed characteristics of the studies including meta-analyses are shown in Table 1.
| Study | Total Study Included | Outcome | Population | Study Included | Prevalence | 95%CI | I2 | Events | Sample size | Analysis Software | Model | Appraisal Tool | AMSTAR-2Quality | Remarks | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (Batra et al. 2020) [] [38] | 65 | Stress | All | 17 | 40.3 | 31.4β50.0 | 99.1 | 6543 | 16235 | CMA | REM | NIH | Moderate | HCPs |
| Anxiety | All | 46 | 34.4 | 29.5β39.7 | 99.1 | 17749 | 51596 | ||||||||
| Nurses | 8 | 39.3 | 27.5β52.5 | 98.9 | 8606 | 21899 | |||||||||
| Physicians | 8 | 32.5 | 21.9β45.2 | 99 | 7117 | 21899 | |||||||||
| Depression | All | 46 | 31.8 | 26.8β37.2 | 99.2 | 16906 | 53164 | ||||||||
| Nurses | 9 | 42.4 | 30.4β5.4 | 99 | 9301 | 21936 | |||||||||
| Physicians | 9 | 39.1 | 27.3β52.2 | 98.4 | 8577 | 21936 | |||||||||
| 2 | (Krishnamoorthy et al. 2020) [] [39] | 23 | Stress | All | 5 | 33 | 19β50 | 98.4 | 1986 | 6017 | STATA | REM | NOS | Moderate | Mixed |
| Anxiety | All | 16 | 24 | 16β32 | 99.6 | 9201 | 38337 | ||||||||
| Depression | All | 16 | 25 | 19β32 | 99.4 | 9425 | 37701 | ||||||||
| Sleep Disturbance | All | 5 | 43 | 28β59 | 99.2 | 2010 | 4675 | ||||||||
| 3 | (Pappa et al. 2020) [] [41] | 13 | Anxiety | All | 12 | 23.2 | 17.8β29.1 | 99 | 7367 | 31756 | MetaXL | REM | NOS | Moderate | HCPs |
| Nurses | 6 | 25.8 | 19.2β33.0 | 98 | 5160 | 19999 | |||||||||
| Physicians | 6 | 21.7 | 15.3β29 | 97 | 4340 | 19999 | |||||||||
| Depression | All | 10 | 22.8 | 15.1β31.5 | 99.6 | 7071 | 31014 | ||||||||
| Nurses | 5 | 30.3 | 18.2β43.8 | 99.5 | 5679 | 18742 | |||||||||
| Physicians | 5 | 25.4 | 16.6β35.2 | 98 | 4760 | 18742 | |||||||||
| Sleep Disturbance | All | 5 | 34.3 | 27.5β41.5 | 98 | 2935 | 8558 | ||||||||
| 4 | (Qiu et al. 2020) [] [42] | 52 | Sleep Disturbance | All | 52 | 39.2 | 36.0β427 | 98.3 | 12446 | 31749 | R | REM | Loney | Low | HCPs/ China |
| Nurses | 41 | 39.4 | 35.7β43.5 | 98.4 | 9878 | 25070 | |||||||||
| Physicians | 3 | 34.2 | 12.6β55.8 | 99.2 | 720 | 2104 | |||||||||
| 5 | (Salari et al. 2020a) [] [44] | 7 | Sleep Disturbance | Nurses | 6 | 34.8 | 24.8β46.4 | 97.4 | 2526 | 7259 | CMA | REM | STROBE | Critically Low | HCPs |
| Physicians | 5 | 41.6 | 27.7β57 | 97.3 | 2286 | 5496 | |||||||||
| 6 | (Salari et al. 2020b) [] [45] | 29 | Stress | All | 8 | 36.4 | 18.3β59.5 | 99 | 1293 | 3551 | CMA | REM | STROBE | Critically Low | HCPs /Frontline |
| Anxiety | All | 17 | 27 | 20.1β35.3 | 95.5 | 2987 | 11062 | ||||||||
| Depression | All | 15 | 20.6 | 13.1β30.9 | 99.1 | 2196 | 10658 | ||||||||
| 7 | (Allan et al. 2020) [] [37] | 9 | Stress | All | 9 | 23.4 | 16.3β31.2 | 96 | 970 | 4147 | R | REM | NIH | Critically Low | HCPs |
| 8 | (Salazar de Pablo et al. 2020) [] [46] | 15 | Stress | All | 3 | 29.9 | 8.9β65.2 | 99.7 | 2030 | 6789 | CMA | REM | MMAT | Moderate | Mixed |
| Anxiety | All | 4 | 22.2 | 12.7β35.8 | 99 | 1713 | 7716 | ||||||||
| Depression | All | 4 | 17.9 | 6.7β40.1 | 99.6 | 1381 | 7716 | ||||||||
| Sleep Disturbance | All | 3 | 44.5 | 38.2β50.9 | 93 | 1553 | 3490 | ||||||||
| 9 | (Ren et al. 2020) [] [43] | 5 | Anxiety | All | 4 | 27 | 12β43 | 99.4 | 1308 | 4843 | STATA | REM | AHRQ | Low | Mixed |
| Depression | All | 3 | 25 | 4β45 | 99.7 | 1166 | 4663 | ||||||||
| 10 | (Pan et al. 2020) [] [40] | 7 | Anxiety | All | 7 | 11.4 | 7.1β15.8 | 99 | 848 | 7441 | STATA | REM | STROBE | Low | Mixed |
| 11 | (Zhang et al. 2021) [] [82] | 26 | Stress | All | 8 | 42.1 | 26.0β60.0 | 99.5 | 3866 | 9183 | R | REM | NIH | Moderate | HCPs/ China |
| Anxiety | All | 23 | 27 | 21.0β34.0 | 99 | 5791 | 21447 | ||||||||
| Depression | All | 18 | 26.2 | 21.0β33.0 | 98.6 | 4930 | 18818 | ||||||||
| Sleep Disturbance | All | 8 | 35.5 | 28.0β42.0 | 98.3 | 4174 | 11758 | ||||||||
| 12 | (Adibi et al. 2021) [] [48] | 19 | Anxiety | All | 19 | 30.5 | 25.6β35.4 | 98.4 | 6669 | 21866 | STATA | REM | NG | Low | HCPs |
| 13 | (Al Maqbali et al. 2021) [] [49] | 93 | Stress | Nurses | 40 | 43 | 37β49 | 98 | 11625 | 27034 | CMA | REM | NOS | Moderate | Nurses |
| Anxiety | Nurses | 73 | 37 | 32β41 | 99 | 30178 | 81561 | ||||||||
| Depression | Nurses | 62 | 35 | 31β39 | 99 | 26947 | 76992 | ||||||||
| Sleep Disturbance | Nurses | 18 | 43 | 36β50 | 96 | 4600 | 10697 | ||||||||
| 14 | (Alimoradi et al. 2021) [] [50] | 62 | Sleep Disturbance | All | 62 | 43 | 39β47 | 99.3 | 25521 | 59350 | STATA | REM | NOS | Low | Mixed |
| 15 | (Bareeqa et al. 2021) [] [51] | 8 | Depression | All | 8 | 31.5 | 20.7β43.5 | 99.3 | 3234 | 10267 | OMA | REM | NOS | Low | Mixed/China |
| 16 | (CΓ©nat et al. 2021) [] [52] | 27 | Stress | All | 4 | 21 | 9.0β43.0 | 99.7 | 1444 | 6878 | R | REM | JBI | Moderate | Mixed |
| Anxiety | All | 23 | 15.9 | 12.2β20.3 | 99 | 5895 | 37076 | ||||||||
| Depression | All | 18 | 14 | 11.0β17.0 | 95.3 | 4781 | 34151 | ||||||||
| Sleep Disturbance | All | 6 | 16 | 8.0β30.0 | 99.8 | 993 | 6209 | ||||||||
| 17 | (Ching et al. 2021) [] [53] | 148 | Stress | All | 40 | 36.4 | 23.2 | 49.7 | 12380 | 34010 | OMA | REM | STROBE | Low | HCPs/Asia |
| Anxiety | All | 117 | 39.7 | 34.3β45.1 | 99.8 | 39557 | 99639 | ||||||||
| Depression | All | 98 | 37.5 | 33.8β41.3 | 99.5 | 38861 | 103628 | ||||||||
| 18 | (Dutta et al. 2021) [] [57] | 33 | Stress | All | 17 | 37.7 | 24.0β52.3 | 100 | 10269 | 27238 | MetaXL | REM | NOS | Low | HCPs |
| Anxiety | All | 31 | 32.5 | 26.4β39 | 99 | 7628 | 23472 | ||||||||
| Depression | All | 30 | 32.4 | 25.6β39.3 | 99 | 12200 | 37655 | ||||||||
| Sleep Disturbance | All | 11 | 36.6 | 36.6β48.3 | 99 | 3810 | 10411 | ||||||||
| 19 | (Hao et al. 2021) [] [60] | 20 | Stress | All | 5 | 25.6 | 11.8β39.4 | 99 | 790 | 3085 | R | REM | AHRQ | Low | HCPs |
| Anxiety | All | 16 | 28.6 | 22.4β36.4 | 99 | 2864 | 10015 | ||||||||
| Nurses | 7 | 23.5 | 15.8β35 | 99 | 1437 | 6113 | |||||||||
| Depression | All | 14 | 24.1 | 16.2β32.1 | 99 | 1915 | 7948 | ||||||||
| Nurses | 5 | 25 | 12.7β37.4 | 96 | 423 | 1692 | |||||||||
| Sleep Disturbance | All | 5 | 44.1 | 31.3β57 | 98 | 1607 | 3643 | ||||||||
| 20 | (Yan et al. 2021) [] [81] | 35 | Stress | All | 4 | 56 | 32β79 | 97 | 428 | 765 | R | REM | STROBE | Low | HCPs /China |
| Anxiety | All | 29 | 41 | 35β47 | 98 | 6439 | 15704 | ||||||||
| Depression | All | 20 | 27 | 20β32 | 94 | 5680 | 21038 | ||||||||
| Sleep Disturbance | All | 8 | 41 | 33β50 | 98 | 3065 | 7476 | ||||||||
| 21 | (Liu et al. 2021) [] [65] | 33 | Stress | All | 5 | 30.6 | 9.1β65.9 | 98 | 979 | 3200 | CMA | REM | NOS | Low | Mixed |
| Anxiety | All | 31 | 32.7 | 29.9β38.2 | 98 | 12340 | 37736 | ||||||||
| Depression | All | 23 | 25.8 | 20.4β31.0 | 98 | 9347 | 36230 | ||||||||
| Sleep Disturbance | All | 8 | 37.3 | 32.1β42.8 | 98 | 3649 | 9784 | ||||||||
| 22 | (Mahmud et al. 2021) [] [66] | 69 | Stress | All | 41 | 44.9 | 37β31.1 | 99.8 | 37170 | 82783 | STATA | REM | STROBE | Low | HCPs |
| Anxiety | All | 75 | 41.4 | 36.2β46.7 | 99.8 | 61038 | 147435 | ||||||||
| Depression | All | 69 | 37.1 | 31.8β42.4 | 99.8 | 53665 | 144649 | ||||||||
| Sleep Disturbance | All | 21 | 43.8 | 35.8β51.7 | 99.4 | 14616 | 33370 | ||||||||
| 23 | (Marvaldi et al. 2021) [] [67] | 70 | Stress | All | 9 | 31.4 | 17.5β47.3 | 99.8 | 7979 | 25412 | OMA | REM | AHRQ | Moderate | HCPs |
| Anxiety | All | 22 | 30 | 24.2β37 | 99.6 | 15583 | 51942 | ||||||||
| Depression | All | 25 | 31.1 | 25.7β36.8 | 996 | 21157 | 68030 | ||||||||
| Sleep Disturbance | All | 10 | 44 | 24.6β64.5 | 99.8 | 5468 | 12428 | ||||||||
| 24 | (Phiri et al. 2021) [] [70] | 83 | Stress | All | 19 | 23.2 | 10.5β35.9 | 99.8 | 10666 | 45976 | STATA | REM | NOS | Moderate | Mixed |
| Anxiety | All | 67 | 21.9 | 18.7β25 | 99.7 | 24296 | 110940 | ||||||||
| Depression | All | 67 | 23.4 | 20.6β26.3 | 99.5 | 28699 | 122644 | ||||||||
| Sleep Disturbance | All | 17 | 24 | 16.4β31.6 | 99.5 | 9626 | 40110 | ||||||||
| 25 | (SantabΓ‘rbara et al. 2021) [] [73] | 71 | Anxiety | All | 71 | 25 | 21β29 | 99.1 | 14641 | 58565 | STATA | REM | JBI | Low | HCPs |
| Nurses | 17 | 27 | 20β34 | 97.8 | 1856 | 6875 | |||||||||
| Physicians | 13 | 17 | 12β22 | 95.6 | 880 | 5177 | |||||||||
| 26 | (Saragih et al. 2021) [] [77] | 38 | Stress | All | 14 | 37 | 25β50 | 99.8 | 5695 | 15391 | STATA | REM | JBI | Low | HCPs |
| Anxiety | All | 33 | 40 | 29β52 | 99.8 | 12453 | 31132 | ||||||||
| Depression | All | 30 | 37 | 29β45 | 99.7 | 16738 | 45238 | ||||||||
| 27 | (Singh et al. 2021) [] [76] | 6 | Stress | All | 6 | 65.1 | 48.2β80.3 | 98.6 | 1577 | 2423 | STATA | REM | NIH | Critically Low | Mixed/ India |
| Anxiety | All | 5 | 35.3 | 26.3β44.9 | 92.3 | 658 | 1863 | ||||||||
| Depression | All | 6 | 35.4 | 25.1β46.4 | 97.6 | 1534 | 4333 | ||||||||
| 28 | (Sun et al. 2021) [] [77] | 47 | Anxiety | All | 44 | 37 | 31β42 | 99.9 | 23828 | 64401 | STATA | REM | NOS | Low | HCPs |
| Nurses | 9 | 34 | 26β41 | 99 | 9310 | 27382 | |||||||||
| Physicians | 9 | 28 | 19β38 | 99.1 | 7667 | 27382 | |||||||||
| Depression | All | 39 | 39 | 31β41 | 99.6 | 30395 | 77936 | ||||||||
| Nurses | 8 | 38 | 30β46 | 99 | 10339 | 27209 | |||||||||
| Physicians | 8 | 33 | 26β40 | 97.9 | 8979 | 27209 | |||||||||
| Sleep Disturbance | All | 9 | 32 | 23β42 | 99.5 | 4040 | 12626 | ||||||||
| 29 | (Varghese et al. 2021) [] [79] | 26 | Stress | Nurses | 10 | 40.6 | 25.6β56.8 | 98.6 | 1707 | 4204 | OMA | REM | Loney | Low | Nurses |
| Anxiety | Nurses | 21 | 33 | 24β43 | 99.4 | 4502 | 13641 | ||||||||
| Depression | Nurses | 17 | 32 | 21β44 | 99.4 | 3934 | 12294 | ||||||||
| 30 | (Wu et al. 2021) [] [95] | 29 | Stress | All | 5 | 41.2 | 19.8β64.5 | 99.8 | 4188 | 10165 | STATA | REM | STROBE | Moderate | Mixed |
| Anxiety | All | 23 | 29 | 23.6β34.7 | 99.4 | 14541 | 50143 | ||||||||
| Depression | All | 23 | 31 | 24.7β37.5 | 99.5 | 12986 | 41889 | ||||||||
| Sleep Disturbance | All | 7 | 47.3 | 38.8β55.8 | 98.7 | 6326 | 13375 | ||||||||
| 31 | (Xia et al. 2021) [] [80] | 17 | Sleep Disturbance | All | 15 | 45.1 | 37.2β53.1 | 98.7 | 5530 | 12261 | STATA | REM | Loney | Moderate | HCPs /China |
| 32 | (Deng et al. 2021) [] [55] | 34 | Anxiety | All | 22 | 40 | 33β46 | 99 | 4560 | 11401 | R | REM | AHRQ | Low | HCPs /China |
| Depression | All | 20 | 31 | 25β37 | 98.4 | 3546 | 11438 | ||||||||
| 33 | (Dong et al. 2021) [] [56] | 22 | Stress | All | 9 | 29.1 | 24.3β33.8 | 96.9 | 4258 | 14631 | STATA | REM | AHRQ | Moderate | HCPs /China |
| Anxiety | All | 22 | 34.4 | 29.5β39.4 | 98.8 | 10338 | 30052 | ||||||||
| Depression | All | 18 | 31.1 | 24.5β37.7 | 99.2 | 6827 | 21953 | ||||||||
| 34 | (Serrano-Ripoll et al. 2021) [] [75] | 13 | Sleep Disturbance | All | 13 | 38 | 37β39 | 99 | 5349 | 14075 | STATA | REM | MU | Moderate | HCPs |
| 35 | (Hossain et al. 2021) [] [62] | 17 | Anxiety | All | 15 | 43.6 | 33.1β54.5 | 99.2 | 6557 | 15038 | STATA | REM | NOS | Low | Mixed/South Asia |
| Depression | All | 14 | 29.9 | 23.9β36.6 | 98.1 | 4984 | 16670 | ||||||||
| 36 | (Li et al. 2021) [] [64] | 65 | Stress | All | 9 | 21.5 | 10.5β34.9 | 99.7 | 5254 | 24439 | STATA | REM | MU | Low | HCPs |
| Anxiety | All | 57 | 22.1 | 18.2β26.3 | 99.4 | 16416 | 74280 | ||||||||
| Depression | All | 55 | 21.7 | 18.3β25.2 | 99.3 | 18373 | 84666 | ||||||||
| 37 | (El-Qushayri et al. 2021) [] [58] | 10 | Stress | All | 6 | 66.6 | 47.6β81.3 | 98 | 1273 | 1911 | CMA | REM | NIH | Moderate | HCPs/Egypt |
| Anxiety | All | 4 | 71.9 | 49.4β86.9 | 98 | 966 | 1344 | ||||||||
| Depression | All | 5 | 65.5 | 46.9β80.3 | 98 | 1090 | 1664 | ||||||||
| 38 | (Jahrami et al. 2021) [] [63] | 11 | Sleep Disturbance | All | 11 | 36 | 21.1β54.2 | 99 | 1747 | 4854 | R | REM | NOS | Moderate | Mixed |
| 39 | (Olaya et al. 2021) [] [69] | 57 | Depression | All | 46 | 24 | 20β25 | 99.3 | 12846 | 53527 | STATA | REM | JBI | Low | HCPs |
| Nurses | 14 | 25 | 18β33 | 97.7 | 1471 | 5883 | |||||||||
| Physicians | 10 | 24 | 16β31 | 96.9 | 1024 | 4266 | |||||||||
| 40 | (Raoofi et al. 2021) [] [71] | 46 | Anxiety | All | 46 | 26.1 | 19β34.6 | 99 | 16065 | 61551 | R | REM | NOS | Low | HCPs |
| Nurses | 31 | 24.7 | 17.6β33.5 | 99 | 3074 | 12447 | |||||||||
| Physicians | 17 | 24 | 12.6β40.9 | 99 | 1239 | 5162 | |||||||||
| 41 | (Salehi et al. 2021) [] [72] | 4 | Stress | All | 4 | 11 | 5β16 | 95 | 217 | 1977 | STATA | REM | STROBE | Moderate | Mixed |
| 42 | (Abdulla et al. 2021) [] [47] | 23 | Stress | All | 12 | 58.1 | 44.8β71.3 | 99 | 2445 | 4209 | Rev | REM | 27-itmes | Moderate | HCPs /India |
| Anxiety | All | 10 | 42.9 | 30.3β55.5 | 98 | 1312 | 3059 | ||||||||
| Depression | All | 5 | 41.9 | 29.2β54.6 | 99 | 2429 | 5796 | ||||||||
| 43 | (Crocamo et al. 2021) [] [54] | 14 | Depression | All | 14 | 23.8 | 16.2β32.2 | 99 | 3373 | 14173 | STATA | REM | NOS | Low | HCPs |
| 44 | (Halemani et al. 2021) [] [59] | 13 | Stress | Nurses | 4 | 37 | 8β66 | 99.6 | 720 | 1946 | STATA | REM | NOS | Low | HCPs |
| Physicians | 3 | 37 | 6β68 | 99 | 343 | 928 | |||||||||
| Anxiety | Nurses | 13 | 42 | 33β50 | 97 | 1750 | 4167 | ||||||||
| Physicians | 12 | 34 | 26β42 | 95 | 1127 | 3315 | |||||||||
| Depression | Nurses | 13 | 42 | 32β50 | 97 | 1750 | 4167 | ||||||||
| Physicians | 12 | 34 | 23β45 | 97 | 1127 | 3315 | |||||||||
| Sleep Disturbance | Nurses | 4 | 44 | 35β53 | 91 | 637 | 1447 | ||||||||
| Physicians | 4 | 35 | 26β43 | 91 | 500 | 1428 | |||||||||
| 45 | (Hosen et al. 2021) [] [61] | 4 | Anxiety | All | 4 | 52 | 32β71 | 96 | 883 | 1699 | STATA | REM | JBI | Low | Mixed/ Bangladesh |
| Depression | All | 4 | 41 | 35β46 | 62.1 | 697 | 1699 | ||||||||
| 46 | (Norhayati et al. 2021) [] [68] | 80 | Stress | All | 20 | 31.7 | 21.3β42.2 | 98 | 4017 | 12673 | Rev | REM | JBI | Low | HCPs/Asia |
| Anxiety | All | 68 | 34.8 | 30.1β38.8 | 100 | 43474 | 124925 | ||||||||
| Nurses | 18 | 36.1 | 23.8β48.4 | 100 | 4178 | 11574 | |||||||||
| Physicians | 18 | 30.1 | 20.6β39.6 | 99 | 2191 | 7279 | |||||||||
| Depression | All | 60 | 34.6 | 30.9β38.4 | 100 | 45779 | 132308 | ||||||||
| Nurses | 19 | 36.6 | 27.1β46.2 | 99 | 3718 | 10159 | |||||||||
| Physicians | 19 | 28.3 | 18.9β37.8 | 99 | 1937 | 6845 | |||||||||
| Sleep Disturbance | All | 12 | 37.9 | 25.4β50.4 | 100 | 5638 | 14877 | ||||||||
| 47 | (Zhao et al. 2021) [] [83] | Stress | All | 5 | 28 | 9.5β59 | 99 | 1212 | 4327 | CMA | REM | Loney | Low | Mixed | |
| Anxiety | All | 14 | 23 | 17.1β30.8 | 98 | 2995 | 13020 | ||||||||
| Depression | All | 11 | 23.9 | 15β35.9 | 99 | 2849 | 11922 | ||||||||
| 48 | (Thakur and Pathak 2021) [] [78] | 20 | Stress | All | 3 | 55.6 | 36β110 | 99 | 1356 | 2438 | REM | NOS | Low | HCPs /Frontline | |
| Anxiety | All | 10 | 27.2 | 18.1β36.3 | 98 | 3229 | 11873 | ||||||||
| Depression | All | 9 | 32 | 18β46 | 99 | 3604 | 11262 | ||||||||
| Sleep Disturbance | All | 3 | 34.4 | 32.5β36.3 | 99 | 1296 | 3768 | ||||||||
| 49 | (Aymerich et al. 2022) [] [84] | 239 | Stress | All | 57 | 40 | 32β47 | 99.87 | 19217 | 48042 | STATA | REM | NOS | Low | HCPs |
| Anxiety | All | 176 | 42 | 35β48 | 99.94 | 86735 | 206513 | ||||||||
| Depression | All | 160 | 33 | 28β38 | 99.95 | 69551 | 210762 | ||||||||
| Sleep Disturbance | All | 55 | 42 | 36β48 | 99.57 | 15569 | 37068 | ||||||||
| 50 | (Hu et al. 2022) [] [86] | 71 | Anxiety | All | 60 | 26.7 | 19.6β34.6 | 100 | 20558 | 76998 | R | REM | JBI | Low | HCPs/China |
| Depression | All | 56 | 28.7 | 19.6β34.6 | 100 | 25655 | 89390 | ||||||||
| Sleep Disturbance | All | 25 | 40.4 | 33.8β47.2 | 99 | 10883 | 26937 | ||||||||
| 51 | (Johns et al. 2022) [] [88] | 55 | Anxiety | Physicians | 30 | 25.8 | 20.4β31.5 | 99.2 | 8586 | 33281 | R | REM | JBI | Low | Physicians |
| Depression | Physicians | 26 | 20.5 | 16β25.3 | 98.9 | 6447 | 31447 | ||||||||
| 52 | (Li et al. 2022) [] [89] | 48 | Sleep Disturbance | All | 48 | 46.4 | 40.3β52.5 | 99.5 | 15322 | 33021 | STATA | REM | AHRQ | Low | Mixed/China |
| 53 | (Rezaei et al. 2022) [] [90] | 24 | Depression | All | 24 | 26 | 18β35 | 10923 | 42010 | R | REM | NOS | Low | HCPs | |
| 54 | (Xiong et al. 2022) [] [93] | 44 | Stress | All | 7 | 27 | 16β38 | 99.8 | 7330 | 27148 | STATA | REM | AHRQ | Low | HCPs /China |
| Anxiety | All | 18 | 17 | 13β21 | 99.5 | 5915 | 34793 | ||||||||
| Depression | All | 15 | 15 | 13β16 | 94.3 | 7293 | 48621 | ||||||||
| Sleep Disturbance | All | 5 | 15 | 7β23 | 99 | 857 | 5711 | ||||||||
| 55 | (Zhang et al. 2022) [] [94] | 88 | Anxiety | All | 88 | 33.6 | 29.7β37.6 | 99.2 | 25222 | 75066 | STATA | REM | STROBE | Low | HCPs |
| 56 | (Εlusarska et al. 2022) [] [91] | 23 | Anxiety | Nurses | 22 | 29 | 18β40 | 99.9 | 12488 | 43062 | R | REM | AHRQ | Low | HCPs |
| Depression | Nurses | 18 | 22 | 15β30 | 99.7 | 8675 | 39430 | ||||||||
| 57 | (Blasco-Belled et al. 2022) [] [85] | 74 | Stress | All | 24 | 32 | 23β42 | 100 | 8122 | 25382 | MetaXL | REM | JBI | Moderate | Mixed |
| Anxiety | All | 66 | 31 | 27β36 | 99 | 22309 | 71966 | ||||||||
| Depression | All | 60 | 31 | 26β35 | 99 | 26269 | 84740 | ||||||||
| 58 | (Huang et al. 2022) [] [87] | 17 | Stress | All | 3 | 17 | 4β34 | 85 | 45 | 265 | CMA | REM | Hoyβs | Low | HCPs/Frontline |
| Anxiety | All | 16 | 32 | 20β44 | 98 | 2494 | 7795 | ||||||||
| Depression | All | 14 | 31 | 21β41 | 97 | 2326 | 7504 | ||||||||
| 59 | (Tran et al. 2022) [] [92] | 7 | Depression | All | 7 | 17.3 | 9.2β27.3 | 100 | 1555 | 8987 | CMA | REM | JBI | Low | HCPs /Vietnam |
| 60 | (Tong et al. 2022) [] [105] | 19 | Stress | All | 10 | 53 | 41.1β64.9 | 78.3 | 3167 | 5976 | R | REM | NOS | Moderate | HCPs |
| Anxiety | All | 19 | 43 | 33.8β52.3 | 99 | 7316 | 17013 | ||||||||
| Depression | All | 19 | 44.6 | 36.1β53.1 | 99 | 7588 | 17013 | ||||||||
| Sleep Disturbance | All | 16 | 42.9 | 33.9β51.9 | 99 | 6612 | 15413 | ||||||||
| 61 | (Andhavarapu et al. 2022) [] [96] | 119 | Stress | All | 119 | 34 | 30β39 | 90 | 39829 | 117143 | CMA | REM | NOS | Moderate | HCPs |
| 62 | (Mamun et al. 2022) [] [103] | 4 | Sleep Disturbance | All | 4 | 51 | 23β79 | 98 | 575 | 1127 | STATA | REM | JBI | Moderate | HCPs/Bangladesh |
| 63 | (Cheung et al. 2022) [] [98] | 6 | Anxiety | All | 6 | 37.8 | 28.7β46.9 | 96 | 1230 | 3253 | STATA | REM | JBI | Moderate | HCPs/Asia |
| Depression | All | 6 | 39.8 | 29β50.5 | 97 | 1295 | 3253 | ||||||||
| 64 | (Hasen et al. 2023b) [] [100] | 8 | Depression | All | 7 | 40 | 23β57 | 99 | 1101 | 2752 | STATA | REM | NOS | Moderate | HCPs/Ethiopia |
| Sleep Disturbance | All | 3 | 37 | 13β58 | 98 | 334 | 904 | ||||||||
| 65 | (Athe et al. 2023) [] [97] | 11 | Stress | All | 6 | 50.4 | 22.6β78.2 | 99 | 585 | 1161 | RevMan | REM | Critically Low | HCPs/India | |
| Anxiety | All | 10 | 42.9 | 30.3β55.5 | 98 | 1302 | 3036 | ||||||||
| Depression | All | 8 | 35.4 | 24.5β46.3 | 97 | 1114 | 3147 | ||||||||
| 66 | (Sialakis et al. 2023) [] [107] | 14 | Anxiety | All | 14 | 41.4 | 30.3β52.9 | 99 | 3221 | 7780 | MedCalc | REM | JBI | Moderate | HCPs |
| Depression | All | 14 | 33.8 | 24.7β43.6 | 98 | 2630 | 7780 | ||||||||
| 67 | (Gheshlagh et al. 2023) [] [99] | 12 | Anxiety | All | 12 | 23 | 18β27 | 98 | 6891 | 29960 | STATA | REM | NOS | Moderate | HCPs/ Asia |
| Depression | All | 11 | 20 | 14β27 | 99 | 5890 | 29448 | ||||||||
| 68 | (Wang et al. 2023) [] [106] | 14 | Stress | Nurses | 14 | 65.4 | 55.9β79.9 | 99 | 13902 | 21257 | STATA | REM | NOS | Moderate | HCPs |
| 69 | (Khobragade and Agrawal 2023) [] [101] | 39 | Stress | All | 23 | 43 | 30β56 | 99 | 3494 | 8125 | R | REM | NOS | Critically Low | HCPs/India |
| Sleep Disturbance | All | 16 | 35 | 28β44 | 97 | 1741 | 4974 | ||||||||
| 70 | (Lee et al. 2023) [] [102] | Stress | All | 107 | 25.5 | 22.5β28.6 | 100 | 47070 | 184588 | R | REM | JBI | Moderate | HCPs | |
| Nurses | 42 | 27.4 | 22.5β32.5 | 99 | 10016 | 36554 | |||||||||
| Physicians | 42 | 22.4 | 16.4β29.1 | 99 | 5635 | 25155 | |||||||||
| Anxiety | All | 272 | 28.7 | 26.5β31 | 99 | 84831 | 295578 | ||||||||
| Nurses | 85 | 31.5 | 26.9β36.3 | 99 | 22899 | 72695 | |||||||||
| Physicians | 81 | 26.9 | 23β31 | 98 | 10072 | 37443 | |||||||||
| Depression | All | 274 | 28.5 | 26.5β30.7 | 99 | 94019 | 329891 | ||||||||
| Nurses | 98 | 28 | 24.5β31.7 | 99 | 24327 | 86881 | |||||||||
| Physicians | 89 | 25.3 | 21.8β29 | 99 | 10417 | 41175 | |||||||||
| Sleep Disturbance | All | 54 | 24.4 | 19.4β29.9 | 99 | 7536 | 30886 | ||||||||
| Nurses | 14 | 26 | 16β37.3 | 99 | 1644 | 6324 | |||||||||
| Physicians | 15 | 16 | 10.2β22.7 | 95 | 632 | 3948 | |||||||||
| 71 | (Sharma et al. 2023) [] [104] | Stress | All | 22 | 36 | 23.7β48.2 | 99 | 2875 | 7985 | R | OMA | JBI | Moderate | HCPs/India | |
| Anxiety | All | 20 | 25 | 18.4β31.6 | 98 | 1953 | 7811 | ||||||||
| Depression | All | 21 | 20.1 | 15.6β24.6 | 97 | 2055 | 10222 | ||||||||
| Sleep Disturbance | All | 6 | 18.9 | 9.9β28 | 95 | 296 | 1565 | ||||||||
| 72 | (Hasen et al. 2023a) [] [108] | 13 | Stress | All | 9 | 51 | 41β62 | 98 | 1929 | 3815 | STATA | REM | NOS | Moderate | HCPs/Ethiopia |
| Anxiety | All | 8 | 46 | 30β61 | 99 | 1802 | 3703 |
3.2 Quality appraisal
Each meta-analysis was assessed using the AMSTAR-2 tool. Twenty- nine meta-analyses were classified as moderate quality and thirty-seven as low quality. Only six meta-analyses were classified as critically low quality [37,44,45,76,97,101].
3.3 Prevalence of stress
Stress was reported in 42 meta-analyses among HCPs. The estimation of prevalence for stress varied between 11% [72] and 66.6% [58] (Fig 2: Forest Plots). The pooled prevalence of stress from was 37% (292,245/854,852 participants, 95% CI 32.87β41.22) with 95% PI: 14.86β66.3. There was significant heterogeneity between meta-analyses when it came to estimating the prevalence of stress (p< 0.0001, I2 = 99.9%). In the subgroup analysis, the prevalence of anxiety among nurses was determined to be 42.6% (n = 5; 95% CI = 30.49β55.27, I2 = 99%), as shown in Fig 3: Forest Plots. However, the analysis for physicians was not conducted due to an insufficient number of available meta-analyses. In sensitivity analysis, none of the meta-analyses resulted in changes to the pooled prevalence estimates greater than a 2%. The prevalence rate estimates for stress were considered to be suggestive evidence (class III) (Seen Table 2).
Forest plot of the prevalence of stress among HCPs stress (N = 42).
Forest plot of the prevalence of stress among nurses (N = 5).
| No | Total | Event | Prevalence % | Random effects (95% CI) | Random effects p-value | 95% Prediction Interval | I, %2 | Egger Test | Begg | Class of Evidence | Sensitivity Analysis | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stress | ||||||||||||
| HCPs | 42 | 854852 | 292245 | 37 | 32.87β41.22 | <0.0001 | 14.86β66.3 | 99.9 | 0.19 | 0.79 | III | Β± 2% |
| Nurses | 5 | 90995 | 37970 | 42.4 | 30.49β55.27 | <0.0001 | 8.59β85.22 | 99.9 | 0.87 | 1 | III | Β± 3% |
| Anxiety | ||||||||||||
| HCPs | 55 | 2310774 | 734036 | 31.8 | 29.2β34.61 | <0.0001 | 15.24β54.83 | 99.9 | 0.23 | 0.53 | III | Β± 1% |
| Nurses | 12 | 321415 | 105438 | 31.6 | 28.33β35.14 | <0.0001 | 19.54β46.86 | 99.6 | 0.31 | 0.58 | III | Β± 1% |
| Physician | 9 | 160937 | 43219 | 26.3 | 22.89β30.10 | <0.0001 | 14.98β42.05 | 99.2 | 0.65 | 1 | III | Β± 1% |
| Depression | ||||||||||||
| HCPs | 54 | 2349613 | 698808 | 29.4 | 27.13β31.84 | <0.0001 | 15.01β49.62 | 99.9 | 0.16 | 0.84 | III | Β± 0.5% |
| Nurses | 11 | 305385 | 96564 | 32 | 28β36.35 | <0.0001 | 17.98β50.34 | 99.8 | 0.82 | 0.94 | III | Β± 1% |
| Physician | 8 | 154935 | 43268 | 28.4 | 24.32β32.78 | <0.0001 | 15.37β46.32 | 99.8 | 0.98 | 0.62 | III | Β± 1% |
| Sleep | ||||||||||||
| HCPs | 36 | 502780 | 191673 | 36.9 | 33.78β40.05 | <0.0001 | 19.99β57.70 | 99.7 | 0.24 | 0.04 | III | Β± 1% |
| Nurses | 5 | 50797 | 19285 | 37.1 | 30.71β44.1 | <0.0001 | 30.71β44.06 | 99.3 | 0.33 | 0.61 | III | Β± 2% |
| Physician | 4 | 12976 | 4138 | 30.6 | 20.04β43.77 | <0.0001 | 2.68-87-62 | 99.5 | 0.48 | 1 | III | Β± 3% |
3.4 Prevalence of anxiety
Fifty-five meta-analyses estimated the prevalence of anxiety among HCPs, and ranged from 11.4% [40] to 71.9% [58]. The pooled prevalence of anxiety was 31.8% (734,036/2,310,774 participants, 95% CI 29.2β34.61) with 95% PI: 15.24β54.83 (Fig 4: Forest Plots) among all HCPs and there was considerable heterogeneity (p< 0.0001, I2 = 99.9%). In the subgroup analyses, in terms of professional status, the pooled prevalence of anxiety was 31.6% (n = 12; 95% CI = 28.33β35.14, I2 = 99%) and 26.3% (n = 9; 95% CI = 22.89β30.10, I2 = 99%) for nurses, and physicians respectively (Figs 5 and 6: Forest Plots). A sensitivity analysis, specifically a leave-one-out analysis, revealed that none of the meta-analyses had an impact on the global prevalence estimate of anxiety symptoms greater than 1%. Suggestive evidence (class III) was found for the estimated prevalence of anxiety in the case of HCPs, nurses and physicians.
3.5 Prevalence of depression
A total of 54 meta-analyses examined the prevalence of depression among HCPs during the COVID-19 pandemic and results ranged from 14% [52] to 65.6% [58]. The pooled prevalence was 29.4% (698,808/2,349,613 participants, 95% CI 27.13β31.84) with 95% PI: 15.01β49.62 (Fig 7: Forest Plots) and there was a significant result in terms of the study heterogeneity (p< 0.0001, I2 = 99.9%). In subgroups analyses, the prevalence of depression was higher among nurses 32% (n = 11; 95% CI = 28β36.35, I2 = 99%) compared with physicians 28.4% (n = 8; 95% CI = 24.32β32.78, I2 = 99%) (Figs 8 and 9: Forest Plots). In the sensitivity analysis, the pooled prevalence remained stable when one meta-analysis was excluded at a time, with variations of less than 1%. Class III evidence revealed suggestive findings regarding the estimated prevalence of depression among HCPs, nurses, and physicians.
3.6 Prevalence of sleep disturbance
Sleep disturbance was assessed in 36 meta-analyses, with a calculated pooled prevalence of 36.9% (191,673/502,780 participants, 95% CI 33.78β40.05) with 95% PI: 19.99β57.70 (Fig 10: Forest Plots) with significant differences in terms of the meta-analyses heterogeneity presented (p< 0.0001, I2 = 99.7%). The prevalence of sleep disturbance ranged from 15.01% [93] to 47.3% [95]. In subgroup analyses, the prevalence of sleep disturbance was found to be higher among nurses at 37.1% (n = 5; 95% CI = 30.71β44.1, I2 = 99%) compared to physicians, where it was 30.6% (n = 4; 95% CI = 20.04β43.77, I2 = 99%) (Figs 11 and 12: Forest Plots). The estimated prevalence rate of sleep disturbance was deemed to be suggestive evidence (Class III). The pooled prevalence did not change in sensitivity analysis by excluding one meta-analyses each time by less than 3%.
3.7 Publication bias
The result of Eggerβs regression test for all pooled prevalence indicates that publication bias was insignificant, showing no evidence of publication bias Table 2.
4. Discussion
To the best of our knowledge, this is the first umbrella review to provide a comprehensive synthesis of the estimate of the aggregate data prevalence symptoms of stress, anxiety, depression, and sleep disturbance among HCPs, physicians, and nurses during the entire COVID-19 pandemic.
In the present umbrella review, which utilizes aggregate data from 71 meta-analyses, the most prevalent problems among healthcare professionals (HCPs) were found to be stress (37%), followed by sleep disturbance (36.9%), anxiety (31.8%), and depression (29.4%). The findings among HCPs are slightly higher than the prevalence estimates from the general population (prevalence estimates of 27% for sleep disturbance; 36% for stress; 26% for anxiety and 28% for depression) during the COVID-19 pandemic [109]. In addition, a report by the World Health Organization prior to the COVID-19 pandemic estimated that the global prevalence of anxiety and depression was 4.4% and 3.6% respectively [110]. While some of this disparity may result from different methodological approaches used, the prevalence of depression and anxiety during the COVID-19 pandemic appears to have been higher than before the outbreak. The rise in mental health problems among HCPs may have been triggered by the uncertainty surrounding the pandemic, increased workload, and the fear of family transmission, any, or all of which may also contribute to the higher prevalence of these conditions.
The results of this umbrella review revealed higher prevalence rates compared with two previous reviews of meta-analyses [18,20]. These include 10 meta-analyses which reported prevalence rates during COVID-19 among HCPs: 25% for anxiety and 24% for depression [18]. Another umbrella review involving 18 meta-analyses found stress in 36% of the sample, depression in 26%, anxiety in 27% and sleep disturbance in 32% among HCPs during the COVID-19 pandemic [20]. It is important to highlight that the previous reviews included meta-analyses published before March 2021, while this current review included studies published until January 2024. As a result, the current umbrella review includes more meta-analyses compared to the two previous umbrella reviews [18,20]. This umbrella review therefore extends the scientific knowledge of the impact of COVID on mental health of HCPs.
The results of our study suggest that the psychological trauma experienced by HCPs during the SARS and MERS epidemics was lower than that experienced during the COVID-19 pandemic [111β114]. However, the difference between COVID-19 and previous pandemics could be explained by the high mortality rate and infectious potential of the COVID-19 pandemic. The results of this study suggest that the COVID-19 pandemic has had a significant negative effect on the psychological health of HCPs. One important lesson that should be learned is that early detection and treatment are carried out to prevent these types of psychological issues developing into more complex ones.
The result of this analysis demonstrates a higher level of anxiety, depression and sleep disturbance among nurses compared to physicians. One explanation for this may be that nurses are involved in more prolonged and closer contact to COVID-19 patients than physicians [115β117]. Another possible reason might be due to the higher number of nurses included in original studies.
The current review found that the overall pooled prevalence varied between the meta-analyses, for example ranging between 1% [72] and 66.6% [58] for stress, 11.% [40] and 71.9% [58] for anxiety, 14% [52] and 65.6% [58] for depression, and 15% [93] and 47.3% [95] for sleep disturbance. This could be linked to the varying COVID-19 infection and mortality rates in the countries in which the studies were conducted. Other possible reasons might relate to the healthcare system, cultural norms of HCPs, and their perceptions of stress, anxiety, depression, and sleep disturbance which in turn might be influenced by their working conditions, exposure to pandemics, intensity of lockdown and social distancing strategies, and perceived support. For instance, the result of the meta-analysis by El-Qushayri [58] showed the highest prevalent rate in terms of stress, anxiety and depression. This may be because this meta-analysis included only HCPs from Egypt, which in turn might indicate that the Egyptian healthcare system was severely affected by COVID-19 compared to other countries [118].
The finding of this umbrella review highlights significant negative effect that the COVID-19 pandemic has had on the psychological health of HCPs, further emphasizing the need for regular mental health assessment and management in this population. Due to the increasing number of complex traumas that HCPs are experiencing, special attention should be paid to the development of positive traumatic growth. The higher prevalence of stress, anxiety, depression, and sleep disturbance among HCPs have important implications for both the policies and practices of the healthcare system under consideration. It is important to identify effective interventions for HCPs such as the behavioural and educational interventions that have been suggested, including the development of a sense of coherence, positive thinking, and social support [119β121]. Currently there is a lack of evidence about the effectiveness of some psychological interventions that were adapted for use during COVID-19 pandemic specifically for healthcare workers [122,123].
Heterogeneity was significant in the majority of the analyses; several reasons can be attributed to this prominence. Firstly, the individual studies within each meta-analysis might differ substantially in terms of their design, sample sizes, interventions or exposures, and outcome measures. These variations can lead to differing effect sizes or conclusions, making the integration of results into a cohesive summary more complex. Furthermore, heterogeneity can arise from variations in the quality of these studies. While some research might have been meticulously conducted with strict inclusion criteria and rigorous methodologies, other studies on healthcare workers may have inherent biases or confounding factors due to the rapidly changing nature of the pandemic, the pressures of lockdowns, and their effects.
The unique characteristics and experiences of healthcare workers during the COVID-19 crisis, compounded by the challenges of lockdown measures, have the potential to further amplify this variability. Factors such as age, gender, ethnicity, and underlying health conditions, when combined with the stress, increased workload, and challenges of the pandemic and lockdown situations, can significantly influence study outcomes. Additionally, methodological differences in individual studies, like the use of a wide variety of questionnaires to measure symptoms, varied cut-off points, and severity thresholds, as well as the absence of a consistent βgold standardβ for diagnostic interviews, can contribute to increased heterogeneity. In the context of the umbrella review, synthesizing findings from such a diverse collection of meta-analyses, particularly those focused on healthcare workers during this unparalleled period marked by fluctuating lockdown measures, poses a formidable challenge. Such complexity may constrain the robustness and precision of the conclusions drawn.
One of the most critical factors that policymakers need to consider when it comes to implementing effective interventions is the availability of organizational support. This can be done through various work-based interventions such as implementing shorter working hours and having buddy systems [124]. In addition, other measures such as providing mental health consultants and tele counselling can also help reduce the impact of the outbreak of disease on the well-being of staff members [125,126].
4.1 Limitations
Several limitations must be taken into consideration when interpreting the results of this umbrella review even though one strength of this methodology is that it provides comprehensive evidence regarding the mental health problems that were faced by HCPs during the COVID-19 pandemic, First, there is a possibility of selection bias. For example, non-English language meta-analyses were not included in this umbrella review, and this may introduce a selection bias. Second, it may be the case that some meta-analyses may have included the same primary studies and that there is consequently a significant study overlap between the meta-analyses included in this review. However, since the results of the studies were then combined with other studies, and a new result was presented, these were regarded as being new studies [25]. Further, several researchers address overlapping by removing some of the reviews with higher rates of overlapping [26,127]. Although removing the overlapping meta-analyses solves the problem of dependent effects, it might introduce a bias of its own. Excluding one of two overlapping meta-analyses from an umbrella review will bias the overall estimate [128,129]. In addition, Hennessy and Johnson [127] clearly mention that the overlap of primary studies included in a meta-review is not necessarily a bias but often can be a benefit.
Third, the various methodologies of the primary studies that were included in the meta-analyses, in terms of sampling methods, assessment tools, operational definitions of the symptoms and study length, might have affected the sensitivity and specificity with regard to detecting the prevalence estimations of stress, anxiety, depression, and sleep disturbance [130]. Finally, it should be noted that stress, anxiety, depression, and sleep disturbance varied between the HCPs studied. Therefore, future research should focus on the difference contexts of estimation prevalence between HCPs and should report the prevalence in each group.
5. Conclusion
In summary, this umbrella review systematically analyses the currently available evidence on the prevalence of stress, anxiety, depression, and sleep disturbance among HCPs in relation to COVID-19. It revealed that the incidence of these symptoms is high in the HCP population. However, there is wide variation in the degree of these conditions among this HCP population. This may be due to the varying experiences of COVID-19 and the cultural differences in the countries where the studies have been carried out. It is clear from the current evidence that strategies involving multi-level interventions are required to develop effective interventions that can help improve the mental health and well-being of HCPs and foster post-traumatic growth. Further research needs to address the limitations of the existing literature, in order to enable the authorities, providers, and patients to improve the quality of mental health on the part of HCPs.